This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Nobuyuki Suzuki: Innovator in Alzheimer's Disease Treatment
Introduction
Nobuyuki Suzuki is a notable inventor based in Japan, recognized for his contributions to the field of medical science, particularly in the treatment of Alzheimer's disease. His innovative work focuses on developing therapeutic agents that target cognitive impairment.
Latest Patents
Nobuyuki Suzuki holds a patent for a humanized antibody known as the Humanized Anti-Amyloid-.beta. Oligomer Antibody. This antibody is designed to specifically bind to Aß oligomers while avoiding Aß monomers. It serves as an anti-cognitive impairment agent and a therapeutic agent for Alzheimer's disease. The patent outlines methods for preventing and treating cognitive impairment and Alzheimer's disease through the administration of this antibody.
Career Highlights
Throughout his career, Nobuyuki Suzuki has dedicated himself to advancing medical research and developing innovative solutions for cognitive disorders. His work has the potential to significantly impact the lives of individuals suffering from Alzheimer's disease.
Collaborations
Nobuyuki Suzuki has collaborated with Tsuguo Kubota, contributing to the development of groundbreaking therapies aimed at combating cognitive decline.
Conclusion
Nobuyuki Suzuki's innovative approach to treating Alzheimer's disease through the development of targeted antibodies showcases his commitment to improving cognitive health. His contributions to medical science are invaluable and hold promise for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile